Amino Acid Catabolism
| Category | Mechanisms |
|---|---|
| Also known as | amino acid breakdown, protein catabolism |
| Last updated | 2026-04-14 |
| Reading time | 4 min read |
| Tags | mechanismmetabolism |
Overview
Amino acid catabolism is the set of metabolic pathways that dispose of amino acids surplus to biosynthetic needs. Amino acids — obtained from dietary protein, body protein turnover, or de novo synthesis — can be used for protein synthesis, serve as precursors for other biomolecules, or be catabolized for energy. Because amino acids contain nitrogen, catabolism requires two coordinated operations: removal of the amino group (which must be disposed of safely, as ammonia is toxic) and conversion of the carbon skeleton into a TCA cycle intermediate or acetyl-CoA.
The twenty standard amino acids are classified by how their carbon skeletons enter central metabolism. Glucogenic amino acids yield TCA cycle intermediates or pyruvate and can be converted to glucose via gluconeogenesis. Ketogenic amino acids (leucine and lysine, uniquely) yield acetyl-CoA or acetoacetate and can produce ketone bodies. Several amino acids are both glucogenic and ketogenic.
Amino acid catabolism plays major roles during fasting (muscle proteolysis releases amino acids for gluconeogenesis), in high-protein feeding (nitrogen disposal dominates), and in inborn errors of metabolism (phenylketonuria, maple syrup urine disease, homocystinuria). These disorders often require specialized diets and can produce severe neurologic and metabolic consequences if untreated.
Mechanism / Process
-
Deamination or transamination. Most amino acids first transfer their amino group to alpha-ketoglutarate via aminotransferases, producing glutamate and the corresponding alpha-keto acid. Glutamate dehydrogenase then releases free ammonia from glutamate, linking this nitrogen flow to the urea cycle.
-
Direct deamination. A few amino acids (serine, threonine, histidine) undergo direct deamination or dehydration. Branched-chain amino acids (leucine, isoleucine, valine) begin with a shared transamination and then follow parallel oxidative decarboxylations.
-
Carbon skeleton fates. The resulting alpha-keto acid is oxidized or rearranged to enter central metabolism. For example, alanine becomes pyruvate directly; aspartate becomes oxaloacetate; glutamate becomes alpha-ketoglutarate; methionine, valine, isoleucine, and threonine converge on succinyl-CoA via propionyl-CoA.
-
Ketogenic entry. Leucine, lysine, and parts of tryptophan, tyrosine, phenylalanine, and isoleucine yield acetyl-CoA or acetoacetate, feeding ketogenesis rather than gluconeogenesis.
-
One-carbon metabolism. Serine, glycine, methionine, and histidine contribute one-carbon units through folate and methionine cycles, supporting nucleotide synthesis and methylation reactions.
-
Essential amino acid fates. Nine amino acids cannot be synthesized de novo and must come from diet: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine. Their catabolism follows dedicated pathways, many with inborn errors of clinical importance.
-
Branched-chain amino acids. BCAAs are catabolized primarily in peripheral tissues, especially muscle. Branched-chain aminotransferase initiates the pathway; branched-chain alpha-keto acid dehydrogenase (BCKDH) catalyzes the oxidative decarboxylation step, deficient in maple syrup urine disease.
-
Regulation. Protein load, insulin/glucagon ratio, and cortisol regulate flux. During fasting, glucagon and cortisol increase amino acid uptake into liver, gluconeogenic flux, and urea output.
Key Players / Molecular Components
- Aminotransferases. ALT, AST, branched-chain aminotransferase, others.
- Glutamate dehydrogenase (GDH). Central nitrogen-mobilizing enzyme.
- Branched-chain alpha-keto acid dehydrogenase. Shared BCAA catabolic step.
- Phenylalanine hydroxylase (PAH). Tetrahydrobiopterin-dependent enzyme; deficiency causes PKU.
- Cystathionine beta-synthase. Methionine/homocysteine catabolism; deficiency causes homocystinuria.
- Methylmalonyl-CoA mutase. Odd-chain and branched-chain entry to succinyl-CoA; requires B12.
Clinical Relevance / Therapeutic Targeting
Inborn errors of amino acid catabolism are numerous: phenylketonuria (PAH deficiency), maple syrup urine disease (BCKDH deficiency), homocystinuria (CBS deficiency), tyrosinemia, methylmalonic acidemia, propionic acidemia, and many others. Management typically includes protein restriction, cofactor supplementation (B12, biotin, BH4), and in some cases enzyme replacement or liver transplant. In oncology, BCAA metabolism is altered in many cancers and is a therapeutic target. In metabolic disease, BCAA elevation is a biomarker of insulin resistance. The urea cycle connection means catabolic disorders can present with hyperammonemia.
Peptides That Target This Pathway
- Glucagon — promotes hepatic amino acid uptake and catabolism.
- Insulin — suppresses proteolysis, reducing amino acid flux.
- Growth hormone — anabolic; opposes catabolic breakdown.
- IGF-1 — anabolic growth effects.
- GLP-1 analogs — influence BCAA and amino acid handling through glucose-insulin effects.
- Mechano growth factor (MGF) — muscle-specific IGF splice variant with anabolic actions.
Related Topics
Related entries
- Gluconeogenesis— Gluconeogenesis is the metabolic pathway by which the liver and kidneys synthesize new glucose from non-carbohydrate precursors, maintaining blood sugar during fasting and prolonged exercise.
- Ketogenesis— Ketogenesis is the hepatic process of converting excess acetyl-CoA from fatty acid oxidation into ketone bodies, providing an alternative fuel source for the brain and other tissues during fasting.
- Gluconeogenesis— The hepatic and renal synthesis of glucose from non-carbohydrate precursors such as lactate, amino acids, and glycerol during fasting and exercise.
- Ketogenesis— The hepatic synthesis of ketone bodies from acetyl-CoA during fasting and carbohydrate restriction, providing an alternative fuel for brain and peripheral tissues.
- Nucleotide Synthesis— The de novo and salvage pathways that produce the purine and pyrimidine nucleotides required for DNA, RNA, cofactors, and energy metabolism.
- Urea Cycle Metabolism— The hepatic cycle that converts ammonia from amino acid breakdown into urea for safe renal excretion.